Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

“Tan Sheet” Participates In Capitol Hill Briefing On PSE Diversion

This article was originally published in The Tan Sheet

Executive Summary

“The Tan Sheet” moderates a briefing Acura hosted to inform congressional staff about the impact of its tamper-resistant single-ingredient Nexafed on PSE diversion and for Sen. Joe Manchin to discuss Rx drug abuse. The story includes a link to a video of the event.


Related Content

Hydrocodone Reclassification Could Benefit Long-Acting Opioids


Related Companies